[Grants-dist] Research Opportunities
grants-dist at ces.clemson.edu
grants-dist at ces.clemson.edu
Wed Jan 16 09:03:48 EST 2008
Weekly NIH Funding Opportunities and Notices
NIH Guide for Grants and Contracts
January 11, 2008
http://grants.nih.gov/grants/guide/WeeklyIndex.cfm?WeekEnding=01-11-2008
NIH Requiring Mandatory Use of the Electronic Financial Status Report
System in the eRA Commons Beginning October 1, 2007
* * * * * * *
Commerce Business Daily for this week:
http://people.clemson.edu/~wahba/CBDs/CBD-01-11-08.htm
http://people.clemson.edu/~wahba/CBDs/CBD-01-10-08.htm
http://people.clemson.edu/~wahba/CBDs/CBD-01-09-08.htm
http://people.clemson.edu/~wahba/CBDs/CBD-01-08-08.htm
http://people.clemson.edu/~wahba/CBDs/CBD-01-07-08.htm
NSF, NIH and ACS deadlines have been updated in the Research
Opportunities continuous list at the bottom of the page. To view the
continuous list of Research Opportunities and items you may have missed
please click on the following URL:
http://people.clemson.edu/~wahba/opportunities.htm
* * * * * * * *
To view The Grant Advisor http://www.grantadvisor.com/tgaplus/
* * * * * * *
To see what's in the (State Science and Technology Institute) STTI
Weekly Digest go to the bottom of this document.
* * * * * * * *
Current Fringe Rates, Indirect Rates, and Tuition Remission Rates are
listed at the bottom.
* * * * * * * *
January 25, 2008
National Institute of Dental and Craniofacial Research
Developing Complex Models of Oral Health Behavior (R21)
(RFA-DE-08-009) (letter of intent due Jan. 25, 2008; application due
Feb. 22, 2008)
Application Receipt Date(s): November 14, 2008
http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-08-009.html
January 28, 2008
National Heart, Lung, and Blood Institute
National Human Genome Research Institute
Development and Application of New Technologies to Targeted Genome-wide
Resequencing in Well-Phenotyped Populations (R01)
(RFA-HL-08-004) (letter of intent due Jan. 28, 2008; application due
Feb. 28, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-08-004.html
January 29, 2008
National Cancer Institute
National Institute of Neurological Disorders and Stroke
Limited Competition: Adult Brain Tumor Clinical Trials Consortium (U01)
(RFA-CA-08-504) (letter of intent due Jan. 29, 2008; application due
Feb. 29, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-504.html
February 11, 2008
National Cancer Institute
Application of Emerging Technologies for Cancer Research (R21/R33)
(RFA-CA-08-007) (letter of intent due Feb. 11, 2008; application due
March 11, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-007.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-008.html
National Cancer Institute
Innovative Technologies for Molecular Analysis of Cancer (R21)
(RFA-CA-08-006)(letter of intent due Feb. 11, 2008; application due
March 11, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-006.html
National Cancer Institute
Innovative Technology Solutions to Cancer Sample Preparation (R21/R33/
SBIR [R43/R44]/ STTR [R41/R42]))
(RFA-CA-08-009) (letter of intent due Feb. 11, 2008; application due
March 11, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-009.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-010.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-013.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-014.html
National Cancer Institute
Innovative and Applied Molecular Analysis Technologies for Cancer (SBIR
[R43/R44]/ STTR [R41/R42])
(RFA-CA-08-011) (letter of intent due Feb. 11, 2008; application due
March 11, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-011.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-012.html
February 13, 2008
National Institute on Drug Abuse
Institute of Neurosciences, Mental Health and Addiction
Substance Abuse and Glial Regulation of Nervous System Function (R03/
R01/ R21)
(RFA-DA-08-013) (letter of intent due Feb. 13, 2008; application due
March 13, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-08-013.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-08-014.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-08-015.html
February 20, 2008
National Cancer Institute
Comprehensive Minority Institution/Cancer Center Partnership (U54)
(RFA-CA-08-001)(letter of intent due Feb. 20, 2008; application due
March 20, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-001.html
February 26, 2008
National Institute for Occupational Safety and Health
Expansion of the National Mesothelioma Virtual Registry and Tissue Bank
(U24)
(RFA-OH-08-002) (letter of intent due Feb. 26, 2008; application due
March 26, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-OH-08-002.html
February 27, 2008
National Institute on Drug Abuse
HIV-1 and Host Genetics in Drug Using Populations and Model Organisms
(R01)
(RFA-DA-08-009) (letter of intent due Feb. 27, 2008; application due
March 27, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-08-009.html
February 29, 2008
USAID
US Agency for International Development
Program Research for Strengthening Services (PROGRESS)
Modification 2
http://www07.grants.gov/search/search.do?mode=VIEW&oppId=40328
March 31, 2008
NSF
National Science Foundation
Petascale Computing Resource Allocations
Grant
http://www.grants.gov/search/search.do?&mode=VIEW&flag2006=true&oppId=16
399
April 29, 2008
National Cancer Institute
Innovative Technologies for Molecular Analysis of Cancer (R21)
(RFA-CA-08-006) (letter of intent due April 29, 2008; application due
May 29, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-006.html
National Cancer Institute
Application of Emerging Technologies for Cancer Research (R21/R33)
(RFA-CA-08-007) (letter of intent due April 29, 2008; application due
May 29, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-007.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-008.html
National Cancer Institute
Innovative Technology Solutions to Cancer Sample Preparation
(R21/R33/SBIR [R43/R44]/ STTR [R41/R42])
(RFA-CA-08-009) (letter of intent due April 29, 2008; application due
May 29, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-009.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-010.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-013.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-014.html
National Cancer Institute
Innovative and Applied Molecular Analysis Technologies for Cancer (SBIR
[R43/R44]/ STTR [R41/R42])
(RFA-CA-08-011) (letter of intent due April. 29, 2008; application due
May 29, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-011.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-012.html
May 17, 2008
NIH Roadmap Initiatives
Institutional Clinical and Translational Science Award (U54)
(RFA-RM-08-002) (letter of intent due May 17, 2008; application due
June. 17, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-08-002.html
August 24, 2008
National Cancer Institute
Innovative Technologies for Molecular Analysis of Cancer (R21)
(RFA-CA-08-006) (letter of intent due Aug. 24, 2008; application due
Sept. 24, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-006.html
National Cancer Institute
Application of Emerging Technologies for Cancer Research (R21/R33)
(RFA-CA-08-007) (letter of intent due Aug. 24, 2008; application due
Sept. 24, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-007.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-008.html
National Cancer Institute
Innovative Technology Solutions to Cancer Sample Preparation (R21/R33/
SBIR [R43/R44]/ STTR [R41/R42])
(RFA-CA-08-009) (letter of intent due Aug. 24, 2008; application due
Sept. 24, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-009.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-010.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-013.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-014.html
National Cancer Institute
Innovative and Applied Molecular Analysis Technologies for Cancer (SBIR
[R43/R44]/ STTR [R41/R42])
(RFA-CA-08-011) (letter of intent due Aug. 24, 2008; application due
Sept. 24, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-011.html
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-08-012.html
September 21, 2008
NIH Roadmap Initiatives
Institutional Clinical and Translational Science Award (U54)
(RFA-RM-08-002) (letter of intent due Sept. 21, 2008; application due
Oct. 21, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-08-002.html
October 14, 2008
National Institute of Child Health and Human Development
Studies of Antimicrobial and Prebiotic Activity of Oligosaccharides
(R01)
(RFA-HD-08-004) (letter of intent due Oct. 14, 2008; application due
Nov. 14, 2008)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-08-004.html
* * * * * * *
SSTI Weekly Digest
A Publication of the State Science and Technology Institute
SSTI, 5015 Pine Creek Drive, Westerville, Ohio 43081
Phone: (614) 901-1690 http://www.ssti.org <http://www.ssti.org/>
In the January 9, 2008 Issue:
* Tech Talkin' Govs, Part I
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Govs#Govs>
* Federal Spending Bills Contain 2,526 R&D Earmarks, AAAS Analysis
Finds
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Earmarks#Earmarks>
* Two New Initiatives Aim to 'Innovate' and 'Accelerate' Wisconsin
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Wisconsin#Wisconsin>
* Illinois Boosts TBED Strategy with New Entrepreneurship
Initiatives
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Illinois#Illinois>
* Report Identifies Benefits to U.S. Biopharmaceutical Industry
through Investments in Technology Infrastructure
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Report#Report>
* SSTI's Annual Conference Set for Oct. 14-16, 2008
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#Conference#Conference
>
* SSTI Job Corner
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#SSTI#SSTI>
* People
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#People#People>
Copyright State Science & Technology Institute 2008. Redistribution to
all others interested in tech-based economic development is strongly
encouraged. Please cite the State Science & Technology Institute
whenever portions are reproduced or redirected.
ARCHIVED ISSUES (1996-present): Previous issues of the SSTI Weekly
Digest are available and searchable on our website:
http://www.ssti.org/Digest/digest.htm
<http://www.ssti.org/Digest/digest.htm> An index of all state and local
stories may be found at:
http://www.ssti.org/Digest/Indices/indexstate.htm
<http://www.ssti.org/Digest/Indices/indexstate.htm>
TO SUBSCRIBE/UNSUBSCRIBE: Subscriptions to the SSTI Weekly Digest are
free. To subscribe, please visit:
http://www.ssti.org/Digest/digform.htm
<http://www.ssti.org/Digest/digform.htm> To unsubscribe, please visit:
http://www.ssti.org/Digest/digform_unsubscribe.htm
<http://www.ssti.org/Digest/digform_unsubscribe.htm>
________________________________
Tech Talkin' Govs, Part I
SSTI's eighth annual Tech Talkin' Govs series highlights new and
expanded TBED proposals from governors' state-of-the-state, budget and
inaugural addresses. With mounting budget deficits spanning the nation,
this year's anticipated overarching theme is proposals aimed at mending
states' finances with less focus on the introduction of new initiatives.
The first installment of the series includes excerpts from California
and New York.
California
Gov. Arnold Schwarzenegger, State-of-the-State Address
<http://gov.ca.gov/index.php?/press-release/5089/> , Jan. 8, 2007
"California leads the nation in biotechnology ... nanotechnology ...
medical technology ... information technology. And we will soon be
recognized as the leader in clean technology.
"Worldwide, clean-tech investments are up by 50 percent in the first
nine months alone last year... so I have asked myself, what must we do
in this chamber to help fulfill this future? ...
"... Let me tell you about some of the ideas of our legislative leaders.
Speaker Nunez has made research into alternative energy and
transportation fuels a top priority this year. Speaker Nunez, I will
work with you on that."
New York
Gov. Eliot Spitzer, State-of-the-State Address
<http://www.ny.gov/governor/keydocs/2008sos_speech.html> , Jan. 9, 2008
"We must focus with a singular purpose on an agenda for economic growth
and opportunity. To do this, we need a world-class education system from
Pre-K to graduate school. ...
"... Without world class education, we cannot have a world class
economy. Last year we focused on pre-school to grade twelve. This year,
we must also look beyond high school to our colleges and universities.
...
"... If you want to participate in the innovation economy, a high school
diploma is not always enough - you're going to need a college diploma,
or better yet, an advanced degree. We can't strengthen our economy
without the best colleges producing the best-prepared graduates. That's
why our goal must be to make an outstanding higher education affordable
for every New Yorker.
"Last year, I convened a Commission on Higher Education to recommend
what we need to do to make America's largest public system of higher
education one of its very best [see the Dec. 19, 2007
<http://www.ssti.org/Digest/2007/121907.htm#TBED> issue of the Digest].
Last month, they spoke. Today, you and I need to begin acting on their
recommendations.
"Over the next five years, we must hire 2,000 new full-time faculty
members for SUNY and CUNY, including 250 eminent scholars - the type of
professors whose research draws grants and collaboration from around the
globe, and whose stature lifts entire campuses.
"We must create an Innovation Fund for cutting-edge research at New
York's public and private colleges, similar to the National Science
Foundation, and the National Institutes of Health. Supercharging
cutting-edge academic research will also supercharge our innovation
economy.
"We must invest in our community colleges, which train New Yorkers for
high-skilled jobs and serve as the gateway to four-year colleges. ...
"... We will move forward on the University of Buffalo's "2020"
expansion as a centerpiece of our strategy to reinvigorate the economy
of Western New York... we will create a flagship at the other end our
state as well. We will help bring together the University at Stony
Brook, and the world renowned Brookhaven and Cold Spring Harbor
laboratories. The result will be a peerless cross-disciplinary research
engine in the areas of cancer, neurobiology, plant genetics and
bioinformatics. ...
"... But none of this is possible unless we figure out a way to pay for
it. And to do that, we need a new funding source. The finest private and
public colleges and universities in America use the funds from permanent
endowments to achieve excellence. If we are to join their ranks, we must
do so as well. ...
"... Given the investments we must make and the sheer size of our higher
education system, this endowment initially should be at least $4
billion, which would generate $200 million in operating funds each year.
"... We should unlock some of the value of the New York State Lottery,
either by taking in private investment or looking at other financing
alternatives. As we do this, we will assure that the State continues to
regulate all lottery games, and that we continue to receive the more
than $2 billion annually for K to 12 education that the lottery now
provides.
"... As our health care reforms embrace common sense, they must also
embrace the cutting edge. Last year, working together with both houses
of the Legislature and guided by the leadership of Lieutenant Governor
Paterson, we created a $600 million Stem Cell Research Fund. He and I
share the belief that, yes, stem cell research is an economic
development opportunity, but it is also a moral imperative. I am pleased
to report that, this week, the first round of grants went out, making
New York's stem cell fund the fastest in the country to go from green
light to grant making."
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
Federal Spending Bills Contain 2,526 R&D Earmarks, AAAS Analysis Finds
A new AAAS analysis of the disappointing federal budget for 2008 reveals
Congress's obsession with earmarks is back with a vengeance,
guaranteeing that competition for the remaining federal funds for R&D
will be even more fierce.
While lower than 2006, earmarks consumed $4.5 billion of the federal R&D
budget, scattered among 2,526 projects AAAS was able to identify.
Congressional earmarks amounted to $939 million in the omnibus
appropriations bill signed last month by President Bush and $3.5 billion
in the Department of Defense appropriations bill enacted in November,
said Kei Koizumi, head of the AAAS R&D Budget and Policy Program
<http://www.aaas.org/spp/rd/> .
"Although earmarked R&D funding declines in 2008 compared to previous
years," Koizumi said, "in a tight budget environment, earmarks once
again crowd out hoped-for increases in competitively awarded research
programs."
Koizumi's analysis found that the Department of Energy and the
Department of Agriculture are the most heavily earmarked domestic R&D
agencies, with nearly 10 percent of Energy's R&D portfolio siphoned off
and 18 percent of USDA's. After being earmark-free for the first years
of its existence, the Department of Homeland Security is slated to get
$82 million in R&D earmarks in 2008.
On the positive front, the National Institutes of Health and the
National Science Foundation remain earmark-free.
Earmarks tend to be geographically concentrated. The top 10 state
recipients of earmarks-led by California with $294 million-account for
44 percent of all earmarked funds, Koizumi found. The top 10 states are
a mixture of the most populous states and states with politically
powerful congressional appropriators.
The complete AAAS earmark analysis
<http://www.aaas.org/spp/rd/earm08c.htm> includes a link to a
spreadsheet of all 2008 R&D earmarks by amount, state, performer or
project, and agency. The AAAS R&D Budget and Policy Program site also
includes details of all R&D funding in the omnibus bill for the top R&D
agencies <http://www.aaas.org/spp/rd/new.htm> .
Few Washington pundits hold any prospects for much of the 2009 budget
passing before the fiscal year begins Oct. 1 - or even before the
presidential election in November. Given that scenario, the full budget
is not likely to be considered before the January inaugural and next
session of the "new" Congress. Earmarks cannot be attached to Continuing
Resolutions (yet) so 2009, like 2007, could be a pork-free budget year.
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
Two New Initiatives Aim to 'Innovate' and 'Accelerate' Wisconsin
Gov. Jim Doyle announced two new initiatives focusing on investments in
manufacturing R&D and increasing angel and venture capital investment to
grow new businesses.
With the goal of remaining globally competitive, the governor's new
Innovate Wisconsin initiative offers tax incentives to encourage
manufacturers to increase R&D. Specifically, the plan calls for new
'Innovate' tax credits that are given to companies who increase spending
on R&D by 25 percent over their three-year average. Companies would
receive a $1 tax credit for every $1 spent above this threshold, which
is capped at 50 percent of its tax liability, according to the
governor's office. Additionally, the plan calls for machines and
equipment used in manufacturing R&D to be exempt from sales and property
tax.
Gov. Doyle also announced the creation of Accelerate Wisconsin, an
initiative to encourage new start-up businesses through grants, loans
and tax credits. This initiative builds upon Act 255
<http://www.legis.state.wi.us/2003/data/acts/03Act255.pdf> , a measure
to expand angel and seed tax credits by $5 million, which was widely
debated but ultimately approved during last year's legislative session
(see the Oct. 31, 2007
<http://www.ssti.org/Digest/2007/103107.htm#Wisconsin> issue of the
Digest). By 2015, the total amount of tax credits is expected to reach
$100 million, leveraging a minimum of $400 million in private
investment, according to the governor's office. The Accelerate Wisconsin
initiative also comprises three new components:
* The Accelerate Grant and Loan Program will double funding for
current technology grants and loans by directing $5 million annually to
provide seed money to start-up companies and small businesses and supply
the matching funds required for federal research grant applications;
* The Capital Gains Re-Investment Initiative will allow
individuals a limited 100 percent capital gains exclusion of up to $10
million for long-term capital gains reinvested in qualifying Wisconsin
businesses; and,
* Accelerating Capital Investment to New Start-ups by raising the
current cap of $1 million in tax-creditable angel investment per
business to $4 million. This proposal increases flexibility in allowing
new start-up companies to receive financing from any combination of
angel or venture investors to the maximum of $4 million in total
tax-creditable investment.
Both initiatives are part of the next phase of the governor's Grow
Wisconsin Agenda, a plan to jumpstart the state's economy through
investments in TBED (see the Sept. 19, 2003
<http://www.ssti.org/Digest/2003/091903.htm#Wisc> issue of the Digest).
The plan was updated and expanded in 2005 to include a number of
additional investments, including seed funding for the Biomedical
Technology Alliance to promote research, tax incentives for businesses
to locate high-wage jobs in distressed areas, establishing a
Manufacturing Competitiveness Council, and increasing the minimum number
of math and science credits required for high school graduation (see the
Sept. 26, 2005 <http://www.ssti.org/Digest/2005/092605.htm#Wisconsin>
issue of the Digest).
More information on the Innovate Wisconsin initiative is available from
the governor's press office at:
http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=308
1
<http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=30
81>
For more information on Accelerate Wisconsin, please visit:
http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=307
8
<http://www.wisgov.state.wi.us/journal_media_detail.asp?locid=19&prid=30
78>
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
Illinois Boosts TBED Strategy with New Entrepreneurship Initiatives
With rumors of recession building, several of the nation's governors are
announcing new TBED-focused initiatives in 2008 - many of which will be
presented to lawmakers for funding in the coming months. In Illinois,
Gov. Rod Blagojevich unveiled two new initiatives encouraging
entrepreneurship to grow high-technology businesses throughout the
state.
Both initiatives focus on supporting new and serial entrepreneurs with
developing and commercializing technologies. The Entrepreneurship in
Residence Program (EIR) provides mentorship by pairing experienced
entrepreneurs with young entrepreneurs to help them start new
businesses. The Chicagoland Entrepreneurial Center (CEC) will administer
the program through a grant totaling $860,000 awarded by the Illinois
Department of Commerce and Economic Opportunity. The CEC will select
qualified entrepreneurs to enroll in the EIR program who, in turn, will
identify promising technologies and match them with young entrepreneurs.
The goal is to help them start a business and move toward a first round
of financing. Each EIR-approved business is eligible to receive up to
$80,000 for prototype development, technology assessments, intellectual
property protection and market assessments.
The second initiative, called the IL-Celerate Program, will guide young
entrepreneurs as they develop technology companies through a 12-week
process that ends with the completion of a prototype-stage product or
service. The Illinois Technology Association (ITA) will initially
sponsor five seed-stage companies through the process, awarding grants
of up to $15,000. IL-Celerate participants also receive incubation
services such as office space, furniture, Internet access, phone
service, and conference facilities in ITA's 26,000-square-foot
technology community center, TechNexus. Total funding for the program is
$120,000.
Elsewhere in the country, states have announced similar initiatives
supporting entrepreneurship as part of an overall TBED strategy. Hoping
to garner support from lawmakers in the coming legislative session,
Minnesota Gov. Tim Pawlenty unveiled a $70 million rural
entrepreneurship initiative to facilitate new business development
through networks, seed funding and tax exemptions (see the Oct. 3, 2007
<http://www.ssti.org/Digest/2007/100307.htm#Governors> issue of the
Digest).
In Ohio, the TechLift initiative was created earlier this year through
the state's Third Frontier Program to provide direct services to
entrepreneurs in five signature technologies throughout the northeast
region, including advanced materials, biosciences, electronics,
information and communication technologies, and advanced energy (see the
Oct. 10, 2007 <http://www.ssti.org/Digest/2007/101007.htm#Community>
issue of the Digest).
More information on the Entrepreneur in Residence and IL-Celerate
programs are available at:
http://www.commerce.state.il.us/dceo/News/homepage_pr12132007.htm
<http://www.commerce.state.il.us/dceo/News/homepage_pr12132007.htm>
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
Report Identifies Benefits to U.S. Biopharmaceutical Industry through
Investments in Technology Infrastructure
The average cost of bringing an Food and Drug Administration-approved
drug to market could be cut by 25 percent to 48 percent by making
targeted investments in the national biopharmaceutical R&D technology
infrastructure, according to a recent report from the National
Institutes of Standards and Technology. Economic Analysis of the
Technological Infrastructure Needs of the U.S. Biopharmaceutical
Industry cites current costs as averaging $560 million per drug, but
could drop to between $289 million and $421 million. Furthermore, these
improvements can reduce the time from drug identification to clinical
trial completion from a current average of 11 years to sometime between
8-10 years.
The report describes the growing complexity of biopharmaceutical drug
discovery, as a transition is underway from the standard trial-and-error
research process geared towards the treatment of symptoms, to using
computer modeling and knowledge of the body's biochemistry to create
drugs that target the functionality of cellular processes. To increase
the efficiency and quality of new drug production, infrastructure such
as new equipment, software and technology platforms, operating
protocols, and manufacturing processes will need to be further developed
throughout the industry. Additionally, the standardization of these
developments will allow data and knowledge to be shared through all
stages of drug development, from basic research to clinical trials and
commercial manufacturing.
The report's authors surveyed individual researchers and technical
experts involved in biopharmaceutical R&D to provide quantitative
estimates on how the advancement of the technical infrastructure can
reduce cost and development times and improve the quality of drug
development. Their analysis concentrated on the intricacies of four
specific areas of technology infrastructure:
* Bioimaging - Techniques such as MRI and ultrasound that allow
biological processes to be visually identified.
* Biomarkers - Measurements that allow the body's biology to be
measured, for functions such as monitoring disease progression and the
response to drugs.
* Bioinformatics - The creation and interpretation of data, often
based on advanced computing, modeling techniques and shared databases of
information.
* Gene expression - The processes through which certain genes and
proteins are involved in biological processes.
Two other components of drug production were targeted within the report:
the commercial manufacturing of drugs, including the scale-up from
clinical trial production, processing and quality control; and
post-market analysis, including safety tracking, post-market clinical
trials and determining cost-effectiveness to alternative treatments.
The report finds the biopharmaceutical industry invested $1.2 billion on
infrastructure-related products and services in 2005 (compared to $21
billion in total R&D spending), spread throughout technology
infrastructure, commercial manufacturing and post-market analysis. Of
this amount, $884 million was spent on technology infrastructure alone.
The largest component of investments was concentrated on gene expression
analysis (30 percent of total infrastructure spending), followed by
biomarkers (24 percent), bioinformatics (22 percent) and bioimaging (15
percent). In addition to the benefits on the time and cost savings in
R&D from investing in this infrastructure, the report estimates the
industry's annual manufacturing costs can be reduced by $1.5 billion, or
about 23 percent.
Economic Analysis of the Technological Infrastructure Needs of the U.S.
Biopharmaceutical Industry provides in greater detail the specific
emerging technologies and scientific discoveries available in the field.
It can be accessed at:
http://www.nist.gov/director/prog-ofc/report07-1.pdf
<http://www.nist.gov/director/prog-ofc/report07-1.pdf>
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
Save the Dates!
SSTI's Annual Conference Set for Oct. 14-16, 2008
As you begin to fill in your 2008 calendar, remember to mark Oct. 14-16,
2008, to attend SSTI's 12th annual conference in Cleveland! Past
attendees know SSTI's conference is the premiere professional
development event for the TBED community. And 2008 will be no exception.
Back by popular demand, we will be offering an array of pre-conference
workshops on Oct. 14.
The InterContinental Hotel Cleveland
<http://www.ichotelsgroup.com/h/d/ic/1/en/hotel/CLEHB/welcome> , site of
this year's conference, is built with state-of-the-art conference
technology, including an automated response system to maximize the
interaction between the audience and speakers. The hotel is located in
the heart of the Cleveland Clinic <http://www.clevelandclinic.org/> ,
which is ranked among America's top three hospitals by U.S.News & World
Report.
Keeping with years past, the conference agenda will be set by SSTI
members to ensure the most timely and relevant topics for transforming
regional economies. Look for more information on SSTI's conference
website <http://www.ssti.org/conference08.htm> soon. Please contact
Noelle Sheets, director of membership services, at sheets @ ssti.org for
sponsorship opportunities and if you have any questions.
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
SSTI Job Corner
Complete descriptions of these opportunities and others are available at
http://www.ssti.org/posting.htm <http://www.ssti.org/posting.htm> .
The BioBusiness Alliance of Minnesota
<http://www.biobusinessalliance.org/> , a nonprofit organization that
represents Minnesota companies, academia and government, is seeking a
bio-network specialist. This position will report to the BioBusiness
Alliance CEO but will work in close partnership with the Southern
Minnesota Initiative Foundation and other statewide constituents to
support the growth of biobusiness in greater Minnesota. A bachelor's
degree is required; a master's or Ph.D. degree is preferred.
The University of Missouri-Columbia (MU) <http://www.missouri.edu/> is
seeking an innovative, energetic and experienced individual to serve as
director of its Office of Technology Management and Industry Relations.
The director will report to the vice chancellor for research at MU and
will be responsible for stimulating the development and
commercialization of advanced technology, protecting university
intellectual property, and transforming technology into successful
enterprises. The university is looking for an individual with a Ph.D. in
science or engineering or a master's degree in science or engineering,
plus a law degree.
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
________________________________
People
Bill Bradley is the new executive director of the Jay County Development
Corp <http://www.jaycountydev.com/> . Bradley fills the vacancy left by
the late Bob Quadrozzi.
Traci Hancock was named executive director of BioNebraska
<http://www.bionebraska.com/> .
Peter Hermann was selected as the N.C. Technology Association's
<http://www.nc-tech.org/> new CEO. Hermann replaces Joan Myers, who
took a position with a software company.
John McIver is serving as interim vice president for research and
economic development at the University of New Mexico
<http://www.unm.edu/> while the school searches for a permanent
replacement to Terry Yates, who passed away in December.
Gary Margules was appointed vice president for research and technology
transfer at Nova Southeastern University <http://www.nova.edu/> .
New Carolina <http://www.newcarolina.org/> , South Carolina's Council on
Competitiveness, has formed the South Carolina Engineering Cluster. Lee
Stogner will lead the cluster <http://www.southcarolinaengineering.org/>
and its steering committee, which represents government, economic
develoment, academia, engineering companies and professional societies
aiming to promote engineering in South Carolina.
Dr. James Weyhenmeyer will become senior vice president for the State
University of New York (SUNY) Research Foundation
<http://www.rfsuny.org/> and SUNY <http://www.suny.edu/> senior vice
provost for research, effective March 3, 2008.
return to the top of the page
<file:///C:\DOCUME~1\wahba\LOCALS~1\Temp\eud3A.htm#top#top>
* * * * * * *
New F&A Schedule (Pending Federal approval)
These rates are expected to be approved and should be used starting
immediately on proposals being developed.
For projects starting on or after July 1, 2007, for the duration of the
award the rates will be:
Organized Research - 47.5%
Instruction - 45.0%
Other Sponsored Activities - 34.0%
For projects starting on or after July 1, 2008, for the duration of the
award the rates will be:
Organized Research - 48.0%
Instruction - 45.0%
Other Sponsored Activities -34.0%
For projects starting on or after July 1, 2009, for the duration of the
award the rates will be:
Organized Research - 48.5%
Instruction - 45.0%
Other Sponsored Activities -34.0%
Example: If you proposal starts September 1, 2007, your rate will be
47.5% for the life of the proposed project.
New Fringe Rates
Faculty - 24.1%
Staff & Post-Docs - 30.2%
Students - 5.1%
Part-time & Retired - 15.9%
FY
Per Semester
Per Summer Session
Total for Year
2008
2,691
1,035
7,452
2009
2,826
788
7,228
2010
2,967
827
7,588
2011
3,115
868
7,966
2012
3,271
911
8,364
Dianne M. Myers
Grants Administrator
College of Engineering and Science
113 Riggs Hall, Box 340901
Clemson, SC 29634-0901
864-656-5534 (p)
864-656-7244 (f)
-------------- next part --------------
An HTML attachment was scrubbed...
URL: https://mail.clemson.edu/pipermail/grants-dist/attachments/20080116/396fdf38/attachment.html
More information about the Grants-dist
mailing list